Australia's most trusted
source of pharma news
Saturday, 05 July 2025
Posted 14 December 2022 AM
CSL CEO Paul Perreault has been a major player on the Australian business scene for the past 10 years and when he steps down next March, he leaves a strong legacy - and big shoes to fill.
The company announced yesterday (Tuesday) that Perreault would retire next year handing the reins to the current COO Dr Paul McKenzie.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.